Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00281853 · ClinicalTrials.gov registry record
Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for Cancer
A clinical trial, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- 15
- Enrollment target
NCT00281853 is a clinical trial that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 15 participants.
The verdict
NCT00281853 has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
RATIONALE: Learning about the effects of chemotherapy and biological therapy on nerve function may help doctors plan treatment and help patients live more comfortably. PURPOSE: This clinical trial is studying peripheral neuropathy in patients who are receiving chemotherapy or biological therapy for cancer.
Interventions
- PROCEDURE management of therapy complications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2005-03 |
| Est. Completion | 2007-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00281853
The ClinicalTrials.gov registry entry for NCT00281853 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which management of therapy complications is the first listed.
NCT00281853 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00281853 about?
NCT00281853 is a clinical study titled "Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for Cancer". RATIONALE: Learning about the effects of chemotherapy and biological therapy on nerve function may help doctors plan treatment and help patients live more comfortably. PURPOSE: This clinical trial is studying peripheral neuropathy in patients who are receiving chemotherapy or biological therapy for...
What is the current status of trial NCT00281853?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2005-03. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00281853?
The interventions under investigation include: management of therapy complications (PROCEDURE).
Who is sponsoring clinical trial NCT00281853?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.